Amring Pharmaceuticals Inc recalls Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals
Recalled June 21, 2023 · FDA recall D-0871-2023 · Amring Pharmaceuticals
Hazard
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity. · FDA Class III
Units
48,989 bottles
Sold at
Nationwide in the USA.
Description
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Product
Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30
Manufacturer(s)
Amring Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →